Dr. Waqqas Afif
If you are interested in learning more about any of the clinical and research studies below or would like to volunteer as a research subject, please email: miirecherche.ibdresearch@muhc.mcgill.ca.
Collaboration with Dr. Greg Rosenfeld, University of British Columbia
Study Title: Pro-Active Fecal Calprotectin Monitoring to Improve Patient Outcomes in Ulcerative Colitis: A Prospective Randomized Control Trial (PROMOTE-UC)
Study Title: Pilot study to assess de-escalation of ustekinumab therapy in patients with Crohn’s disease
Study Title: Therapeutic drug monitoring guided early optimization of Adalimumab in Crohn’s disease. A randomized open-label study
Collaboration with Dr. Sasha Bernatsky, Research Institute of the McGill University Health Centre
Sponsor: Canadian Institutes of Health Research (CIHR)
Study Title: Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs
Study Title: A pilot study assessing performance of point-of-care testing for infliximab, adalimumab, C-reactive protein, and fecal calprotectin in inflammatory bowel disease patients with a secondary loss of response
Dr. Talat Bessisow
If you are interested in learning more about any of the clinical and research studies below or would like to volunteer as a research subject, please email: miirecherche.ibdresearch@muhc.mcgill.ca.
Study Title: Correlation between serum drug level and endoscopic mucosal healing in patients with inflammatory bowel disease treated with Vedolizumab and Ustekinumab
Study Title: Quantification and Effects of Ustekinumab on the tissues of the colon.
In collaboration with Dr. Sanjay Murthy, MD, MSc, FRCPC, University of Ottawa, The Ottawa Hospital – General Campus
Study Title: A Randomized Controlled Non-Inferiority Trial Comparing Neoplasia Detection During Colonoscopy Screening With and Without Non-Targeted Biopsies in Adult Colonic Inflammatory Bowel Disease
Sponsor : University Hospital Leuven, Herestraat 49, 3000 Leuven
Study Title: PRognOstiC valuE of rEd Density in Ulcerative Colitis: PROCEED-UC STUDY Predictive value of new endoscopic technique in ulcerative colitis
In collaboration with Collaboration with Hamilton Health Sciences/Dr. Neeraj Narula
Study Title: Tofacitinib for hospitalized acute severe Ulcerative colitis Management
(the TRIUMPH study)
Collaboration with Dr. Saji George, Ph.D., Associate Professor, Canada Research Chair in Sustainable Nanotechnology for Food and Agriculture
Study Title: Effect of dietary nanomaterials on the development and disease progression of inflammatory bowel disease
Collaboration with Dr. Bruce Mazer
Study Title: CTTB Biobank and Registry MANAGEMENT FRAMEWORK
Dr. Alain Bitton
If you are interested in learning more about any of the clinical and research studies below or would like to volunteer as a research subject, please email: miirecherche.ibdresearch@muhc.mcgill.ca.
Sponsor: Dr. Paul Moayyedi, McMaster University
Funding: Canadian Institutes of Health Research (CIHR)
Study Title: Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects: the IMAGINE-SPOR chronic disease network
The following 4 studies are part of NIH-NIDDK IBD Genetics Consortium (IBDGC)
- Identifying genes responsible for inflammatory bowel disease
- Mechanisms of microbiota in mucosal inflammation across the biologic demarcation of Ulcerative Colitis
- Mechanisms of intestinal inflammation following ileal resection for Crohn’s Disease
- Understanding the Genetics of Inflammatory Bowel Disease: The Diversity Study (upcoming)
Sponsor: Dr. John D. Rioux, Montreal Heart Institute
Funding: Génome Canada (Rioux), National Institutes of Health (Rioux) and Pfizer Canada Inc. (Rioux)
Study Title: iGenoMed – CHUM: Identification of biomarkers of response to molecularly-targeted therapies in inflammatory bowel diseases
Study Title: Natural History of IBD in Quebec (as part of an initiative by the Canadian Gastro-Intestinal Epidemiology Consortium)
Dr. Alain Bitton & Dr. Terry Sigman
If you are interested in learning more about any of the clinical and research studies below or would like to volunteer as a research subject, please email: miirecherche.ibdresearch@muhc.mcgill.ca.
Sponsor: Dr. Kenneth Croitoru, Mount Sinai Hospital, Toronto ON with funding from Crohn’s and Colitis Canada
Study Title: A Multidisciplinary Human Study on the Genetic, Environmental and Microbial Interactions that Cause IBD (GEM Project)
Dr. Peter Lakatos
If you are interested in learning more about any of the clinical and research studies below or would like to volunteer as a research subject, please email Rita Kohen: rita.kohen@muhc.mcgill.ca
Study Title: Quality of Care Assessment of the MUHC IBD Center: Retrospective and Prospective Assessment of Quality or Care and Outcome Parameters before and after Installation of the IBD Center
Sponsor: McGill IBD Research Group
Study Title: Mechanistic Studies on Fibrogenesis in Crohn Disease